INTRAVENOUS SOLUTIONS MARKET ANALYSIS

Intravenous Solutions Market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Mar 2024
Code : CMI1134
Pages :215
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Intravenous Solutions Market Restraints

Growth of the global intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.